Results
26
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
26 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
VTSC | €56.95 | -3.8% | -26.8% | €2.3b | €74.72 | PB0.8x | E62.7% | 0.4% | Automobiles | ||
SBS | €42.20 | 1.9% | -18.1% | €513.0m | €42.33 | PE42.2x | E21.9% | 1.3% | Healthcare | ||
RTV | €2.48 | 0% | -3.1% | €37.9m | €2.80 | PS13.5x | E116.8% | n/a | Media | ||
STM | €44.10 | 3.5% | -18.0% | €1.1b | €62.44 | PE14.8x | E21.2% | 4.0% | Capital Goods | ||
ISHA | €2.00 | -1.0% | -3.4% | €29.2m | €2.70 | PB2.7x | E86.4% | n/a | Software | ||
TTR1 | €16.45 | -3.2% | -38.2% | €113.6m | €21.50 | PE17.8x | E29.4% | 3.8% | Capital Goods | ||
CHG | €24.60 | 2.5% | 68.5% | €480.9m | €27.00 | PS6.8x | E73.4% | n/a | Healthcare | ||
MTX | €255.00 | 2.9% | 20.1% | €13.7b | €250.14 | PS2.5x | E34.9% | 0.8% | Capital Goods | ||
SANT | €19.35 | -2.5% | -0.8% | €1.2b | €30.42 | PE15.9x | E21.1% | 2.6% | Software | ||
RSL2 | €18.30 | -0.5% | -16.1% | €117.9m | €30.00 | PB1.7x | E58.9% | 0% | Capital Goods | ||
AEIN | €16.75 | -1.8% | -30.6% | €191.7m | €32.63 | PE14.3x | E25.2% | 3.0% | Software | ||
E4C | €12.90 | 1.2% | -32.5% | €45.3m | €40.50 | PE29.9x | E46.7% | 3.6% | Telecom | ||
ADS | €235.80 | 2.3% | 29.3% | €42.1b | €234.75 | PE495.3x | E40.9% | 0.3% | Consumer Durables | ||
BSL | €10.00 | -8.3% | -32.8% | €307.4m | €15.70 | PS1.6x | E84.0% | 0% | Tech | ||
VBK | €17.90 | 2.6% | -59.6% | €1.1b | €31.02 | PE59.3x | E69.6% | 1.1% | Energy | ||
V3S | €10.75 | 1.4% | 101.3% | €86.6m | €10.25 | PS2.3x | E118.7% | 0% | Tech | ||
R3NK | €25.89 | 4.4% | n/a | €2.6b | €31.88 | PE82.2x | E32.8% | 1.2% | Capital Goods | ||
M12 | €15.50 | -1.6% | 94.7% | €283.9m | €27.50 | PE27.6x | E24.4% | 3.2% | Healthcare | ||
GXI | €95.55 | -1.4% | -11.2% | €3.3b | €134.06 | PE28.6x | E22.2% | 1.3% | Pharmaceuticals & Biotech | ||
LPK | €8.12 | 1.6% | 1.1% | €198.7m | €12.05 | PE84.4x | E69.9% | n/a | Tech | ||
EQS | €39.40 | 0% | 90.3% | €394.9m | €37.50 | PS5.5x | E115.5% | 0% | Software | ||
SAP | €192.88 | -2.0% | 55.5% | €225.0b | €207.92 | PE87.9x | E37.7% | 1.1% | Software | ||
MBB | €102.60 | -4.1% | 30.2% | €586.5m | €123.00 | PE31.7x | E33.5% | 1.0% | Capital Goods | ||
SJJ | €12.80 | 8.5% | 52.7% | €134.4m | €19.75 | PS1.4x | E113.5% | 0% | Software |